This is a full and open Sources Sought Notice. This is NOT a solicitation for proposals, quotation abstracts, or quotations. This notice is for informational and planning purposes only and shall not be construed as a solicitation or an obligation or commitment by the Government, nor is it a Request for Proposals (RFP) available at this time. The Wilkes-Barre Veterans Affairs Medical Center (WBVAMC) in Wilkes-Barre, PA has a requirement for Radiopharmaceuticals. Any subsequent procurement will be conducted as a commercial item purchase in accordance with FAR Part 12 and as a Simplified Acquisition Procedure in accordance with FAR Part 13 as an indefinite delivery / indefinite contract. Interested sources may submit a 1 or 2 page capability statement with enough detail for the Government to make an informed decision regarding such capability. The statement should identify supplier's name, address, point of contact, phone and fax numbers, e-mail addresses and business type and size. Any pertinent GSA Schedule numbers with expiration date should be provided. These statements should be submitted electronically no later than 12:00 PM Eastern Standard Time on Tuesday, February 9, 2016 to Ronald J. Kline at [email protected]. This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that the response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to deliver the supplies. Respondents are also advised that the Government is under no obligation to acknowledge receipt of the information or provide feedback about any of the information received. After review of the responses received, the Government may issue a pre-solicitation synopsis and solicitation may be published in Federal Business Opportunities. No proprietary, sensitive, confidential or classified information shall be included with your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation. Schedule of required items: Description Qty Xe-133 Xenon Gas 10mCi Vial Vial 114 I-131 Sodium Iodide Diagnostic Capsule 15 I-131 Sodium Iodide Compounded Capsule Per mCi 5.00 45 I-123 Capsule (200uCi) Capsule 3.00 150 Sodium Pertechnetate Tc-99m Unit Dose(25mCi) 400 Albumin Aggregated (MAA) Tc-99m Unit Dose 80 Oxidronate (HDP) Tc-99m Unit Dose 175 Sestamibi (Generic) Tc-99m Unit Dose 3000 Pyrophosphate (PYP) Kit Vial 3 Albumin Aggregated (MAA) Kit Vial 12 In-111 White Blood Cells Procedure 3 Mebrofenin (Generic) Tc-99m Unit Dose 75 Mertiatide (Mag-3) Tc-99m Unit Dose 20 In-111 Oxyquinoline (Oxine) per uCi 3 Sincalide for Injection-Vial (Kinevac) Vial 20 Sulfur Colloid Filtered Tc-99m Unit Dose 50 Exametazime (Ceretec) WBC Tc-99m Unit Dose 12 Hespan Unit Dose 3 WBC Set-Up for Ceretec Blood Each 12 WBC Set-Up for In-111 Blood Each 3 BioDose/NMIS Monthly Support - Per Month Per System 12 Pentetate(DTPA) Tc99m Unit Dose 1 Ga-67 Gallium Citrate 1.0 mCi (Price per mCi) 24 In-111 Pentetreotide(Octreoscan) 6mCi Unit dose 10 TL-201, Thallous Chloride 1.0 mCi(per mCi) 120 Ultratag Kits(per kit) 100

Bid Protests Not Available